Following CVS, Walgreens and Rite Aid pull Zantac from shelves

Walgreens and Rite Aid followed CVS Pharmacy in halting Zantac sales after the FDA flagged a possible carcinogen in the heartburn drug.

Advertisement

Walgreens temporarily removed the drug from its shelves Sept. 30 “while the FDA continues its review of the products,” a company spokesperson told The New York Times.

Rite Aid is also removing Zantac and other generic ranitidine products from its shelves, The New York Times reports.

Both companies said Zantac bought at their drugstores could be returned for a refund.

Read the full article here.

More articles on pharmacy:
World Pharmacist Day promotes use of safe and effective medicines
USP delays release of updated compounding standards
Americans pay up to 67 times more for drugs than other countries.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

How Leading Pharmacies Stay Stocked And Protect Margins

Thursday, July 23
12:00 PM - 1:00 PM CDT

Presenters: Calvin Hunsicker, SureCostChad O’Connor, SureCost

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.